Human Insulin Drugs And Delivery Device Market

ID: MRFR/Pharma/41099-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Human Insulin Drugs and Delivery Devices Market Research Report By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Intermediate-Acting Insulin, Premixed Insulin), By Delivery Device Type (Insulin Pens, Insulin Pumps, Syringes, Jet Injectors), By Therapeutic Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Human Insulin Drugs And Delivery Device Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.8%
2024 Market Size$ 45.79 Billion
2025 Market Size$ 47.53 Billion
2035 Market Size$ 69.01 Billion
Key Players
Novo Nordisk
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly and Company
Merck & Co.
Trends
  • Technological Advancements in Delivery Devices
  • Personalized Insulin Therapies
  • Increased Patient Education and Awareness
Opportunities
  • Rising Prevalence of Diabetes
  • Government Initiatives and Support
  • Increased Focus on Diabetes Management
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Product Type (USD Billion)
      1. 4.1.1 Rapid-Acting Insulin
      2. 4.1.2 Long-Acting Insulin
      3. 4.1.3 Intermediate-Acting Insulin
      4. 4.1.4 Premixed Insulin
    2. 4.2 Healthcare, BY Delivery Device Type (USD Billion)
      1. 4.2.1 Insulin Pens
      2. 4.2.2 Insulin Pumps
      3. 4.2.3 Syringes
      4. 4.2.4 Jet Injectors
    3. 4.3 Healthcare, BY Therapeutic Application (USD Billion)
      1. 4.3.1 Type 1 Diabetes
      2. 4.3.2 Type 2 Diabetes
      3. 4.3.3 Gestational Diabetes
    4. 4.4 Healthcare, BY Distribution Channel (USD Billion)
      1. 4.4.1 Hospital Pharmacy
      2. 4.4.2 Retail Pharmacy
      3. 4.4.3 Online Pharmacy
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Novo Nordisk (DK)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Sanofi (FR)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Boehringer Ingelheim (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Bristol-Myers Squibb (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Eli Lilly and Company (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Merck & Co. (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 AstraZeneca (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Roche (CH)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Pfizer (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 US MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    5. 6.5 US MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    6. 6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    7. 6.7 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    8. 6.8 CANADA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    9. 6.9 CANADA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    10. 6.10 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    13. 6.13 GERMANY MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    14. 6.14 GERMANY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    15. 6.15 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    16. 6.16 UK MARKET ANALYSIS BY PRODUCT TYPE
    17. 6.17 UK MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    18. 6.18 UK MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    19. 6.19 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    20. 6.20 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    21. 6.21 FRANCE MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    22. 6.22 FRANCE MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    23. 6.23 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    24. 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    25. 6.25 RUSSIA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    26. 6.26 RUSSIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    27. 6.27 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    28. 6.28 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    29. 6.29 ITALY MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    30. 6.30 ITALY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    31. 6.31 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    32. 6.32 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    33. 6.33 SPAIN MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    34. 6.34 SPAIN MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    35. 6.35 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    42. 6.42 CHINA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    43. 6.43 CHINA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    44. 6.44 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    45. 6.45 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    46. 6.46 INDIA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    47. 6.47 INDIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    48. 6.48 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    49. 6.49 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    50. 6.50 JAPAN MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    51. 6.51 JAPAN MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    52. 6.52 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    57. 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    58. 6.58 MALAYSIA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    59. 6.59 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    60. 6.60 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    61. 6.61 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    62. 6.62 THAILAND MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    63. 6.63 THAILAND MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    64. 6.64 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    65. 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    66. 6.66 INDONESIA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    67. 6.67 INDONESIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    68. 6.68 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    69. 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    70. 6.70 REST OF APAC MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    71. 6.71 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    72. 6.72 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    75. 6.75 BRAZIL MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    76. 6.76 BRAZIL MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    77. 6.77 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    78. 6.78 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    79. 6.79 MEXICO MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    80. 6.80 MEXICO MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    81. 6.81 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    82. 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    83. 6.83 ARGENTINA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    84. 6.84 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    85. 6.85 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    99. 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    100. 6.100 REST OF MEA MARKET ANALYSIS BY DELIVERY DEVICE TYPE
    101. 6.101 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    102. 6.102 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY DELIVERY DEVICE TYPE, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY DELIVERY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.3.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.3.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.4.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.4.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.5.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.5.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.6.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.6.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.7.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.7.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.8.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.8.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.9.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.9.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.10.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.10.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.11.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.11.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.12.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.12.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.13.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.13.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.14.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.14.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.15.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.15.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.16.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.16.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.17.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.17.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.18.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.18.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.19.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.19.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.20.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.20.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.21.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.21.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.22.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.22.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.23.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.23.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.24.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.24.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.25.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.25.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.26.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.26.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.27.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.27.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.28.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.28.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.29.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.29.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY DELIVERY DEVICE TYPE, 2025-2035 (USD Billion)
      3. 7.30.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.30.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Human Insulin Drugs And Delivery Device Market Segmentation

Human Insulin Drugs And Delivery Device Market By Product Type (USD Billion, 2025-2035)

  • Rapid-Acting Insulin
  • Long-Acting Insulin
  • Intermediate-Acting Insulin
  • Premixed Insulin

Human Insulin Drugs And Delivery Device Market By Delivery Device Type (USD Billion, 2025-2035)

  • Insulin Pens
  • Insulin Pumps
  • Syringes
  • Jet Injectors

Human Insulin Drugs And Delivery Device Market By Therapeutic Application (USD Billion, 2025-2035)

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

Human Insulin Drugs And Delivery Device Market By Distribution Channel (USD Billion, 2025-2035)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.